Phase I/II Trial of Metronomic Chemotherapy With Daily Dalteparin and Cyclophosphamide, Twice-Weekly Methotrexate, and Daily Prednisone As Therapy for Metastatic Breast Cancer Using Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor Levels As Markers of Response
Wong, N. S.; Buckman, R. A.; Clemons, M.; Verma, S.; Dent, S.; Trudeau, M. E.; Roche, K.; Ebos, J.; Kerbel, R.; DeBoer, G. E.; Sutherland, D. J.A.; Emmenegger, U.; Slingerland, J.; Gardner, S.; Pritchard, K. I.
- 期刊名称Journal of Clinical Oncology
- 作者Wong, N. S.; Buckman, R. A.; Clemons, M.; Verma, S.; Dent, S.; Trudeau, M. E.; Roche, K.; Ebos, J.; Kerbel, R.; DeBoer, G. E.; Sutherland, D. J.A.; Emmenegger, U.; Slingerland, J.; Gardner, S.; Pritchard, K. I.
- 卷第28卷
- 期第5期
- 印刷ISSN0732-183X
- 电子ISSN1527-7755
- 文件大小241.88KB
- 发表时间2010-02-10
- DOI10.1200/JCO.2009.24.0143
- 页码723-730